Jørgen Olsen

Jørgen Olsen

Professor with special responsibilities, Professor

Member of:

    Primary fields of research

    Morphogenesis and differentiation of the gastrointestinal mucosa.
    Special focus is on the bioinformatics interpretation of alterations in molecular profiles (transcriptome, metabolome) during mucosal inflammation. The basic research using mouse models for intestinal inflammation is translated into applied research in inflammatory bowel diseases.

    Current research

    Rectal insulin as treatment for inflammatory bowel disease.
    Using mouse models for colonic inflammation in combination with mouse genetics we have made the invention that colitis in mice can be treated using rectal instillation of insulin. We are currently doing basic research with the purpose of delineating the mechanism of action for rectal insulin. In addition we have initiated clinical collaborations with clinicians in Copenhagen and Zürich with the purpose to conduct proof of concept studies with ulcerative colitis patients

    Professor Gerhard Rogler, University of Zürich
    Professor Yulan Wang, Key Laboratory of Magnetic Resonance in Biological Systems
    Wuhan Institute of Physics and Mathematics


    Director, ”Course in Head, Neck, the Locomotor System and the Peripheral Nervous System” for third semester medical students.

    Development of new teaching concepts:

    • “The Modern Anatomical Theater”
    • “Q + A livestreamed sessions with student and teacher interactions”
    • “Livestreamed Exam TV”
    • “The digital x-ray library”
    • “The digital anatomical museum”


    Possible conflicts of interest

    CEO and CO-founder of Enterotarget ApS, a spin-out company from university of Copenhagen. Enterotarget has a license agreement with University of Copenhagen concerning the patent "Rectal insulin for treatment of inflammatory bowel disease" EP3538132A1

    ID: 11281